| Full Name | Family Physician |
|---|---|
| Speciality | Family Medicine |
| Location | 1509 Augusta Dr, Ada, Oklahoma |
| Authorized Official Name and Position | Valerie M Pack (FAMILY PHYSICIAN) |
| Authorized Official Contact | 9187284942 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Family Physician 1509 Augusta Dr Ada OK 74820-8576 Ph: (918) 728-4942 | Family Physician 1509 Augusta Dr Ada OK 74820-8576 Ph: (918) 728-4942 |
| NPI Number | 1124531736 |
|---|---|
| Provider Enumeration Date | 11/06/2017 |
| Last Update Date | 08/23/2021 |
| Medicare PECOS PAC ID | 0345507851 |
|---|---|
| Medicare Enrollment ID | O20171207001975 |
News Archive
Athena Diagnostics, a leader in neurological diagnostics, today announced the clinical availability of new genetic tests to aid the detection of several rare neurological disorders, including hereditary neuropathy, neuromuscular disease, epilepsy and certain movement disorders. The lab-developed tests are available through Athena Diagnostics, a business of Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services.
Several scientific papers with results from one of Europe's largest health surveys of young children with focus on overweight and obesity, the IDEFICS study, have been published the last years. Research at the Nordic School of Public Health NHV reveals that some types of families seem to be underrepresented in the health survey. This knowledge can prove to be valuable when the data is interpreted and can contribute to efficient actions for improved child health.
Reports from several studies have identified a link between height and general cognitive ability, or intelligence, but the mechanisms underlying this association are not well known. Researchers from the University of Helsinki, University of California San Diego and Boston University found that this association is mediated by cortical surface area.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced receipt of a $750,000 milestone payment under its collaboration with AVEO Pharmaceuticals, Inc.. The milestone payment resulted from AVEO's recent initiation of a Phase 2 clinical trial to evaluate its AV-299 antibody for the treatment of non-small cell lung cancer. AV-299 is a humanized antibody to hepatocyte growth factor (HGF).
BioMS Medical Corp. today reported that Spectral Diagnostics has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) for Toraymyxin(TM). Spectral Diagnostics and BioMS have entered into a services agreement whereby BioMS will assist Spectral, as required, in its commercialization of Toraymyxin(TM), a therapeutic hemoperfusion device for the treatment of severe sepsis. This approval permits Spectral to initiate its planned pivotal trial for Toraymyxin(TM) in the United States.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124531736 | NPI | - | NPPES |
| 200654670A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 5857 (Oklahoma) | Primary |
| Provider Name | Valerie Marie Pack |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1467847921 PECOS PAC ID: 2769766468 Enrollment ID: I20170224000280 |
News Archive
Athena Diagnostics, a leader in neurological diagnostics, today announced the clinical availability of new genetic tests to aid the detection of several rare neurological disorders, including hereditary neuropathy, neuromuscular disease, epilepsy and certain movement disorders. The lab-developed tests are available through Athena Diagnostics, a business of Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services.
Several scientific papers with results from one of Europe's largest health surveys of young children with focus on overweight and obesity, the IDEFICS study, have been published the last years. Research at the Nordic School of Public Health NHV reveals that some types of families seem to be underrepresented in the health survey. This knowledge can prove to be valuable when the data is interpreted and can contribute to efficient actions for improved child health.
Reports from several studies have identified a link between height and general cognitive ability, or intelligence, but the mechanisms underlying this association are not well known. Researchers from the University of Helsinki, University of California San Diego and Boston University found that this association is mediated by cortical surface area.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced receipt of a $750,000 milestone payment under its collaboration with AVEO Pharmaceuticals, Inc.. The milestone payment resulted from AVEO's recent initiation of a Phase 2 clinical trial to evaluate its AV-299 antibody for the treatment of non-small cell lung cancer. AV-299 is a humanized antibody to hepatocyte growth factor (HGF).
BioMS Medical Corp. today reported that Spectral Diagnostics has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) for Toraymyxin(TM). Spectral Diagnostics and BioMS have entered into a services agreement whereby BioMS will assist Spectral, as required, in its commercialization of Toraymyxin(TM), a therapeutic hemoperfusion device for the treatment of severe sepsis. This approval permits Spectral to initiate its planned pivotal trial for Toraymyxin(TM) in the United States.
› Verified 1 days ago
News Archive
Athena Diagnostics, a leader in neurological diagnostics, today announced the clinical availability of new genetic tests to aid the detection of several rare neurological disorders, including hereditary neuropathy, neuromuscular disease, epilepsy and certain movement disorders. The lab-developed tests are available through Athena Diagnostics, a business of Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services.
Several scientific papers with results from one of Europe's largest health surveys of young children with focus on overweight and obesity, the IDEFICS study, have been published the last years. Research at the Nordic School of Public Health NHV reveals that some types of families seem to be underrepresented in the health survey. This knowledge can prove to be valuable when the data is interpreted and can contribute to efficient actions for improved child health.
Reports from several studies have identified a link between height and general cognitive ability, or intelligence, but the mechanisms underlying this association are not well known. Researchers from the University of Helsinki, University of California San Diego and Boston University found that this association is mediated by cortical surface area.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced receipt of a $750,000 milestone payment under its collaboration with AVEO Pharmaceuticals, Inc.. The milestone payment resulted from AVEO's recent initiation of a Phase 2 clinical trial to evaluate its AV-299 antibody for the treatment of non-small cell lung cancer. AV-299 is a humanized antibody to hepatocyte growth factor (HGF).
BioMS Medical Corp. today reported that Spectral Diagnostics has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) for Toraymyxin(TM). Spectral Diagnostics and BioMS have entered into a services agreement whereby BioMS will assist Spectral, as required, in its commercialization of Toraymyxin(TM), a therapeutic hemoperfusion device for the treatment of severe sepsis. This approval permits Spectral to initiate its planned pivotal trial for Toraymyxin(TM) in the United States.
› Verified 1 days ago
Ada Family Medical Center, Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 530 N Monte Vista St, Ada, OK 74820 Phone: 580-310-9510 Fax: 580-436-4447 | |
Central Oklahoma Family Medical Center Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 325 N Monte Vista St, Ada, OK 74820 Phone: 580-436-5111 Fax: 580-925-9149 | |
Central Oklahoma Family Medical Center, Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 905 Colony Drive Bldg, Ada, OK 74820 Phone: 580-925-3286 | |
Hrh Medical Group, Primary Care Of Ada Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1705 Cradduck Rd, Ada, OK 74820 Phone: 580-304-7017 | |
Myhealth Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1601 N Broadway Ave, Ada, OK 74820 Phone: 405-594-0191 | |
Hale Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 428 E 10th St, 429 E. 10th St, Ada, OK 74820 Phone: 580-310-9755 |